CureVac N.V. (CVAC)
Jan 6, 2026 - CVAC was delisted (reason: acquired by BNTX)
4.660
-0.010 (-0.21%)
Inactive · Last trade price on Jan 5, 2026
CureVac Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CureVac stock had an average target of $6.83, with a low estimate of $5.00 and a high estimate of $10.
Price Target: $6.83 (+46.57%)
Analyst Consensus: Hold
Price Target
Analyst Ratings
The average analyst rating for CureVac stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
72.69M
from 535.18M
Decreased by -86.42%
Revenue Next Year
89.92M
from 72.69M
Increased by 23.71%
EPS This Year
-0.47
from 0.72
EPS Next Year
-0.44
from -0.47
Financial currency is EUR.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 110.3M | 111.3M | ||||
| Avg | 72.7M | 89.9M | ||||
| Low | 33.5M | 60.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -79.4% | 53.1% | ||||
| Avg | -86.4% | 23.7% | ||||
| Low | -93.7% | -17.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.13 | -0.16 | |
| Avg | -0.47 | -0.44 | |
| Low | -0.70 | -0.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |